子宫内膜癌前哨淋巴结定位与分期:妇科肿瘤学会文献综述及共识推荐
妇科肿瘤学会(SGO)临床实践委员会和前哨淋巴结工作组审阅现有文献,针对子宫内膜癌手术分期中引入前哨淋巴结定位以减少全面淋巴结清扫相关并发症、同时获取淋巴结状态预后信息提出基于文献的推荐。文章介绍了前哨淋巴结评估在子宫内膜癌患者治疗中的纳入建议。
要点
- 前哨淋巴结定位已引入子宫内膜癌手术分期,目标为减少全面淋巴结清扫相关并发症。
- SGO临床实践委员会和前哨淋巴结工作组审阅文献后提出基于文献的推荐。
- 推荐涉及在子宫内膜癌患者治疗中纳入前哨淋巴结评估。
核心结论
- 文章提出了在子宫内膜癌患者治疗中纳入前哨淋巴结评估的基于文献的推荐。
研究设计与样本
- 妇科肿瘤学会(SGO)临床实践委员会和前哨淋巴结工作组审阅现有文献后形成本文件。
关键数值与推荐
- 推荐涉及在子宫内膜癌患者治疗中纳入前哨淋巴结评估,具体条款原文未详细列出。
临床怎么用
- 原文未据此给出具体临床操作推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The emphasis in contemporary medical oncology has been "precision" or "personalized" medicine, terms that imply a strategy to improve efficacy through targeted therapies. Similar attempts at precision are occurring in surgical oncology. Sentinel lymph node (SLN) mapping has recently been introduced into the surgical staging of endometrial cancer with the goal to reduce morbidity associated with comprehensive lymphadenectomy, yet obtain prognostic information from lymph node status. The Society of Gynecologic Oncology's (SGO) Clinical Practice Committee and SLN Working Group reviewed the current literature for preparation of this document. Literature-based recommendations for the inclusion of SLN assessment in the treatment of patients with endometrial cancer are presented. This article examines.
引用
- Holloway RW, Abu-Rustum NR, Backes FJ, et al. Sentinel lymph node mapping and staging in endometrial cancer: A Society of Gynecologic Oncology literature review with consensus recommendations. Gynecol Oncol. 2017. PMID: 28566221. doi:10.1016/j.ygyno.2017.05.027
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。